Abstract
Routine or elective minor and major surgery in diabetes must be taken equally seriously as the emergency surgery, in each and every aspect related to it. In emergency surgery, each stakeholder is prepared for a certain element of adverse or untoward happening. There is no guarantee that something similar may not happen in the elective cases, be it minor or major surgery, a distinction between the two made below. If it does happen it reflects extremely adversely over all those involved in the process, the hospital set up and can result in unseemly incidents which can undermine the morale of all concerned. In particular, explanation and documentation of the risk factors and the percentage possibility that it can happen in the said elective surgery would be the paramount, among other factors of care.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
An aphorism used by one of the authors is no patient is unfit for anesthesia unless dead. He is only at a higher risk.
- 2.
In the last 10Â years of the practice of first author, there was a hardly a patient with type 2 diabetes who had gained more than 10 kg of weight who was not on pioglitazone with frank edema. Many could relate the weight gain to the beginning of glitazones.
References
Australian Diabetes Society. Peri-operative diabetes management guidelines, July 2012, ADS working group of Vincent Wong, Glynis Ross, Jennifer Wong and David Chipps (chair).
Kelkar SK. Observations on office staff in a remote thermal electric power plant MP India; 1997.
Guillermo U, Umpierrez E, Smiley D, Jacobs S, Peng L, Temponi A, Mulligan P, Umpierrez D, Newton C, Olson D, Rizzo M. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34:256–61.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86.
Dluhy RG, McMahon GT. Intensive glycemic control in the ACCORD and ADVANCE trials. N Engl J Med. 2008;358:2630–3.
Little RR, Rohlfing CL. The long and winding road to optimal HbA1c measurement. Clin Chim Acta. 2013;418:63–71.
Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer – a PET study. J Nucl Med. 1993;34(1):6–11.
Ishizu K, Nishizawa S, Yonekura Y, Sadato N, Magata Y, Tamaki N, Tsuchida T, Okazawa H, Miyatake S, Ishikawa M. Effects of hyperglycemia on FDG uptake in human brain and glioma. J Nucl Med. 1994;35(7):1104–9.
Zhuang HM, Cortes-Blanco A, Pourdehnad M, Adam LE, Yamamoto AJ, Martinez-Lazaro R, Lee JH, Loman JC, Rossman MD, Alavi A. Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders? Nucl Med Commun. 2001;22(10):1123–8.
Mears SC, Lipsett PA, Brager MD, Riley LH III. Metformin-associated lactic acidosis after elective cervical spine fusion: a case report. Spine. 2002;27(22):E482–4.
Mercker SK, Maier C, Neumann G, Wulf H. Lactic acidosis as a serious perioperative complication of antidiabetic biguanide medication with metformin. Anesthesiology. 1997;87(4):1003–5.
Chan NN, Feher MD. Metformin and perioperative risk. Br J Anaesth. 1999;83(3):540–1.
Bailey CJ, Turner RC. Metformin. N Engl J Med. 1996;334(9):574–9.
Thomsen HS, Morcos SK. Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in non-insulin-dependent diabetics after administration of contrast media. ESUR Contrast Media Safety Committee. Eur Radiol. 1999;9(4):738–40.
Jamet P, Lebas de Lacour JC, Christoforov B, Stern M. Fatal case of metformin-induced lactic acidosis after urography in a diabetic patient. Sem Hop. 1980;56(9–10):473–4.
Klow NE, Draganov B, Os I. Metformin and contrast media—increased risk of lactic acidosis? Tidsskr Nor Laegeforen. 2001;121(15):1829.
McCartney MM, Gilbert FJ, Murchison LE, Pearson D, McHardy K, Murray AD. Metformin and contrast media—a dangerous combination? Clin Radiol. 1999;54(1):29–33.
Joslin EP. Joslin’s textbook of diabetes mellitus. 14th ed. Lippincott, Williams and Wilkins, USA 2005, Indian Edition.
Pareek A, et al. Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone. Curr Med Res Opin. 2014;30(7):1257–66.
Quatraro A, Consoli G, Magno M, et al. Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus: a new job for an old drug? Ann Intern Med. 1990;112:678–81.
Krentz A, Bailey C. Oral anti-diabetic agents: current role in type 2 diabetes mellitus. Drugs. 2006;65:385–411.
Fessler B, Alarcon G, McGwin G, et al. Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum. 2005;52:1473–80.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kelkar, S., Muley, S., Ambardekar, P. (2019). Management of Routine Surgery in Diabetes. In: Towards Optimal Management of Diabetes in Surgery. Springer, Singapore. https://doi.org/10.1007/978-981-13-7705-1_6
Download citation
DOI: https://doi.org/10.1007/978-981-13-7705-1_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-7704-4
Online ISBN: 978-981-13-7705-1
eBook Packages: MedicineMedicine (R0)